Covid Vaccination Argentina

gracielle

Registered
anyone know if those of us with J&J can get booster shots right now?
Updated 9 Nov 2021
....People ages 18 years and older who received a J&J/Janssen COVID-19 vaccine at least 2 months ago should get a booster shot. A single dose of the J&J/Janssen COVID-19 vaccine has lower vaccine effectiveness compared to two doses....
 

gracielle

Registered
11 Nov 2021
Gov't to donate nearly one million doses to five countries. Through five decrees signed by President Alberto Fernandez and his cabinet officials such as the Minister of Health, Carla Vizzotti, the national gov't confirmed that it will donate about one million vaccines of the company AstraZeneca UK Limited to three countries in the Caribbean, one in Asia and one on the African continent. "The pandemic constitutes a global challenge that demands a strategy of solidarity aimed at equitable access to vaccines designed to generate immunity against Covid-19″, argues the text. According to their distribution, 2,000 will be sent to the Commonwealth of Dominica, 18,000 to St. Lucia, 450,000 doses to Mozambique, 11,000 to St. Vincent and the Grenadines and 500,000 to South Vietnam....
 

gracielle

Registered
11 Nov 2021 at 2:51am by Fabiola Czubaj with the collaboration of Martín Boerr (Misiones) and Mariela Arias (Santa Cruz).
Covid-19: with less than 60% of the population vaccinated, there are more than 26 million doses not yet administered. The information comes from the Ministry of Health's real-time records; slightly more than half of these units are in the provinces and the rest are awaiting distribution in the cold chambers contracted by the national gov't.

A total of 88.8 million doses for Covid arrived in the country, a sufficient quantity to have completed the scheme for all the groups included in the vaccination campaign....The arrival of another 896,200 doses from Pfizer in the last hours brought the total number of vaccines received in the last 11 months to 88,863,370. The destination? Some 43 million people including children over the age of three, following last month's official decision to extend immunization to the youngest children. But 29.4% of the shipments arrived so far in the campaign are pending application....This newspaper consulted the National Ministry of Health about this stock of vaccines pending application, but did not receive a response by the time this article went to press....
 

FrankPintor

Registered
During the meeting, Minister Acuña hinted at the possibility of liberating the students, firstly, during recess. Although the discussion is not completely settled, there is an agreement to move forward with the youngest students. What has not yet been defined is up to what age it will no longer be required during breaks. In classrooms it will continue to be mandatory. In fact, the school protocol of the City of BA never established that it was mandatory for children in kindergarten, although it did recommend its use.
Didn't take long: https://www.infobae.com/educacion/2021/11/16/los-alumnos-portenos-de-hasta-tercer-grado-ya-no-tendran-que-usar-barbijo-en-el-aula/

From today, the use of masks is no longer mandatory in class for garden and the first cycle of primary school.
 

FrankPintor

Registered
Chile has, rather disgracefully, stopped COVID vaccination until Wednesday with the excuse of the first round of presidential elections there. Vaccination sites are under the control of the Chilean army.
 

FrankPintor

Registered
Posting from sunny, SF Bay Area....
25 Nov 2021 by Zoltan Simon
Interesting study, thanks. It shows very good performance for all of the vaccines used in Argentina (except Cansino, which wasn't included in the sturdy), something that's quite reassuring.

No surprise about the best performer though, I posted this a while back:

From https://www.theatlantic.com/health/archive/2021/10/pfizer-won-vaccine-race-was-there-downside/620276/ this might serve as an admonishment to those in Argentina who weaponized the negotiations with Pfizer to attack the vaccination program.

"Compared with Moderna’s competing shot, Pfizer’s vaccine seems to induce half the amount of virus-fighting antibodies, and is associated with nearly twice as many breakthrough infections, according to two recent studies".

The discussion on dosing and finding the easiest path through the regulatory process is interesting, concluding with "Three doses of Pfizer, at 30 micrograms each, still amount to less material than a single, 100-microgram dose of Moderna". The higher doses produce more side effects, but it might be worth suffering through the fever and other symptoms some of us have experienced after vaccination: "Phase 3 trials of Moderna’s mRNA vaccine produced very similar efficacy numbers; the only hint of a difference was that Moderna’s more potent shot produced more complaints of fever and headaches", but the protection from Moderna seems to be longer lasting: "“It’s surprising that this enormous group of patients [senior citizens] already needs a new dose of Pfizer".
 
Top